A5102646469- RNA modifications and cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Drug-Induced Hepatotoxicity and Protection
- RNA Interference and Gene Delivery
- Cancer Immunotherapy and Biomarkers
- Endoplasmic Reticulum Stress and Disease
Fudan University
2024
The First Affiliated Hospital, Sun Yat-sen University
2024
Zhongshan Hospital
2024
Sun Yat-sen University
2024
Aims Programmed cell death receptor (ligand)‐1 inhibitors (PD‐(L)1), as the preferred immunotherapy, have been widely used in Chinese mainland and drug‐induced liver injury (DILI) has reported. The study aimed to investigate clinical features or risk factors for immunotherapy‐related DILI. Methods Patients who received PD‐(L)1 from January 2020 July 2021 were retrospectively reviewed. likelihood of DILI was adjudicated by Roussel‐Uclaf causality assessment. Results A total 1175 patients...